Schrödinger to Present at Jefferies London Healthcare Conference
Schrödinger (Nasdaq: SDGR), a company leveraging physics-based computational platforms for therapeutics and materials discovery, has announced its upcoming participation at the Jefferies London Healthcare Conference. The company's management will engage in a fireside chat scheduled for Wednesday, November 20, at 8:30 a.m. GMT (3:30 a.m. ET). Interested parties can access the live webcast through the 'Investors' section of Schrödinger's website, where it will remain available for approximately 90 days after the event.
Schrödinger (Nasdaq: SDGR), un'azienda che utilizza piattaforme computazionali basate sulla fisica per la scoperta di terapeutiche e materiali, ha annunciato la sua prossima partecipazione alla Jefferies London Healthcare Conference. Il management dell'azienda parteciperà a un incontro informale programmato per mercoledì 20 novembre, alle 8:30 GMT (3:30 ET). Le parti interessate possono accedere al webcast in diretta nella sezione 'Investitori' del sito web di Schrödinger, dove rimarrà disponibile per circa 90 giorni dopo l'evento.
Schrödinger (Nasdaq: SDGR), una empresa que utiliza plataformas computacionales basadas en la física para el descubrimiento de terapias y materiales, ha anunciado su próxima participación en la Jefferies London Healthcare Conference. La dirección de la empresa participará en una charla informal programada para miércoles 20 de noviembre, a las 8:30 a.m. GMT (3:30 a.m. ET). Las partes interesadas pueden acceder a la transmisión en vivo a través de la sección 'Inversores' en el sitio web de Schrödinger, donde estará disponible durante aproximadamente 90 días después del evento.
슈뢰딩거 (Nasdaq: SDGR), 물리학 기반 계산 플랫폼을 활용하여 치료제 및 물질 발견을 하는 회사,가 제퍼리스 런던 헬스케어 컨퍼런스에 참가할 예정이라고 발표했습니다. 회사 경영진은 11월 20일 수요일 오전 8시 30분 GMT (오전 3시 30분 ET)에 예정된 파이어사이드 챗에 참여할 것입니다. 관심 있는 분들은 슈뢰딩거 웹사이트의 '투자자' 섹션을 통해 생중계 웹캐스트에 접근할 수 있으며, 이벤트 이후 약 90일 동안 이용 가능할 것입니다.
Schrödinger (Nasdaq: SDGR), une entreprise exploitant des plateformes de calcul basées sur la physique pour la découverte de thérapies et de matériaux, a annoncé sa prochaine participation à la Jefferies London Healthcare Conference. La direction de l'entreprise participera à une discussion informelle prévue pour mercredi 20 novembre à 8h30 GMT (3h30 ET). Les parties intéressées peuvent accéder au webinaire en direct via la section 'Investisseurs' du site web de Schrödinger, où il restera disponible pendant environ 90 jours après l'événement.
Schrödinger (Nasdaq: SDGR), ein Unternehmen, das physikbasierte Berechnungsplattformen für therapeutische und Materialentdeckungen nutzt, hat seine bevorstehende Teilnahme an der Jefferies London Healthcare Conference angekündigt. Das Management des Unternehmens wird an einem geplanten Fireside-Chat teilnehmen, der für Mittwoch, den 20. November, um 8:30 Uhr GMT (3:30 Uhr ET) angesetzt ist. Interessierte können über den Bereich 'Investoren' auf der Website von Schrödinger auf das Live-Webcast zugreifen, das etwa 90 Tage nach der Veranstaltung verfügbar bleibt.
- None.
- None.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.
About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.
Founded in 1990, Schrödinger has approximately 850 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104014834/en/
Allie Nicodemo
Schrödinger, Inc.
allie.nicodemo@schrodinger.com
617-356-2325
Source: Schrödinger
FAQ
When is Schrödinger (SDGR) presenting at the Jefferies London Healthcare Conference?
How can I watch Schrödinger's (SDGR) presentation at the Jefferies Conference?
How long will Schrödinger's (SDGR) Jefferies Conference presentation be available to view?
What type of presentation will Schrödinger (SDGR) give at the Jefferies Healthcare Conference?
